Family Medicine Doctors in Hanson, MA Accepting Medicare
1 Family Medicine doctors found. Showing 1 - 1
 Jeffrey P Tannenbaum, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 430 Liberty St, Suite 7, Hanson, MA 02341 Phone: 781-293-3838 Fax: 781-293-3639 |
News Archive
MPM Capital leads Alnara Pharmaceuticals' $35M Series B venture capital financing
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
Landmark multiple myeloma study completes enrolment and method development
Binding Site is pleased to announce that the ground-breaking iStopMM study has reached an important milestone.
Puricore reports increase in sales of 25% in Q3
PuriCore, the life sciences company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, today issues an Interim Management Statement covering the three-month and nine-month periods ending September 30, 2009.
Scientists edit genes in human stem cells
Researchers at the Johns Hopkins School of Medicine have successfully edited the genome of human- induced pluripotent stem cells, making possible the future development of patient-specific stem cell therapies. Reporting this week in Cell Stem Cell, the team altered a gene responsible for causing the rare blood disease paroxysmal nocturnal hemoglobinuria, or PNH, establishing for the first time a useful system to learn more about the disease.
Mutated oncogene triggers aggressive breast cancer
Researchers at Dana-Farber Cancer Institute have identified a molecular interaction that triggers a particularly aggressive form of breast cancer, and suggest that attacking this target with selective drugs might improve treatment.
› Verified 5 days ago